share_log

Theriva Biologics Q3 EPS $(0.33) Beats $(0.39) Estimate

Benzinga Real-time News ·  Nov 10, 2022 17:14

Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.39) by 15.38 percent. This is a 65 percent decrease over losses of $(0.20) per share from the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment